| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
Therapeutics |
Clinical impact ratings GP/FP/Primary care
Physical medicine & rehabilitation Rheumatology
Key Words: adrenal cortex hormones • exercise therapy • tennis elbow
| The first 150 words of the full text of this article appear below. |
METHODS
Design:
randomised controlled trial.
Allocation:
concealed.*
Blinding:
blinded (data collectors, outcome assessors, and data analysts).*
Follow up period:
52 weeks.
Setting:
community setting in Brisbane, Queensland, Australia.
Patients:
198 patients 18–65 years of age (mean age 48 y, 65% men) with symptoms of tennis elbow lasting 
6 weeks. Exclusion criteria included bilateral elbow symptoms, elbow surgery or injury, and nerve involvement.
Intervention:
corticosteroid injection delivered to painful elbow points (with a second injection 2 wk later, if necessary) (n = 65); physiotherapy consisting of elbow manipulation and therapeutic exercise
(8 treatments over 6 wk, plus home exercises) (n = 66); or wait and see (advice to avoid aggravating the pain and to use heat, cold, or braces) (n = 67). All patients were allowed analgesics as needed and received advice on ergonomics.
Outcomes:
subjective global improvement (6 point Likert scale) ("completely recovered" or "much improved" on this scale was considered
Ted Haines, MD, Bernadette Stringer, RN, PhD
McMaster University, Hamilton, Ontario, Canada
Relevant Articles
Evid. Based Med. 2007 12: 37-38.
(in EBM notebook)
Evid. Based Med. 2007 12: 38.
(in EBM notebook)
Evid. Based Med. 2007 12: 63-64.
(in )
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
